A carregar...
Cost-Effectiveness of Dapagliflozin versus Acarbose as a Monotherapy in Type 2 Diabetes in China.
OBJECTIVE:To estimate the long-term cost-effectiveness of dapagliflozin versus acarbose as monotherapy in treatment-naïve patients with type 2 diabetes mellitus (T2DM) in China. METHODS:The Cardiff Diabetes Model, an economic model designed to evaluate the cost-effectiveness of comparator therapies...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Public Library of Science (PLoS)
2016-01-01
|
| Colecção: | PLoS ONE |
| Acesso em linha: | http://europepmc.org/articles/PMC5091768?pdf=render |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|